CUPR Cuprina Holdings (Cayman) Limited
Company Analysis
Latest News
🔴 Cuprina Holdings (Cayman) Limited makes sharp 10.9% drop
CUPR is trading at $4.69, down 10.9% versus the comparison close of $5.26 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 Cuprina Holdings (Cayman) Limited is trading 7% down today on profit-taking after parabolic gains fueled by recent FDA approval and Nasdaq compliance
• The pullback follows a massive rally that saw shares climb from below $0.30 to over $4.00 as traders chased momentum following FDA 510(k) clearance for...
🟢 Cuprina Holdings (Cayman) Limited makes sharp 15.7% jump
CUPR is trading at $6.10, up 15.7% versus the comparison close of $5.27 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 Cuprina Holdings (Cayman) Limited is trading 6.1% down today as shares normalize after extreme volatility
Cuprina Holdings (Cayman) Limited is trading 6.1% down at $4.95 as the stock appears to be normalizing following a period of intense price swings. • The stock...
🔴 Cuprina Holdings (Cayman) Limited makes sharp 10.2% drop
CUPR is trading at $4.73, down 10.2% versus the comparison close of $5.27 during pre-market. This is a price-movement alert; no separate company-specific...
🔴 Cuprina Holdings (Cayman) Limited is trading 31.6% down today as traders take profits following an FDA-driven rally
Cuprina Holdings (Cayman) Limited is trading 31.6% down at $5.75 as the stock pulls back following an extreme multi-day rally triggered by U.S. FDA 510(k)...
🔴 Cuprina Holdings (Cayman) Limited is trading 31% down today as profit-taking follows FDA-driven rally
Cuprina Holdings (Cayman) Limited is trading 31% down at $5.80 as the stock undergoes a period of normalization and profit-taking following a massive rally...
Cuprina's FDA Win Sends Shares Soaring, but Can a $6.5 Million Company Capture a Slice of the $16 Billion Wound Care Market?
Shares of Cuprina Holdings rocketed 112% on Monday after the Singapore-based biomedical firm announced it had won U.S. regulatory clearance for a biological...
Cuprina Holdings Surges 112% on FDA Clearance for Maggot Wound Therapy
Cuprina Holdings (CUPR) received FDA 510(k) clearance for its MEDIFLY Maggots wound care product. The June 15th announcement marks the first FDA-cleared maggot...